- Home
- INM vs FTAIM Comparison
INM vs FTAIM Comparison
Compare INM & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- FTAIM
- Stock Information
- Founded
- INM 1981
- FTAIM N/A
- Country
- INM Canada
- FTAIM United States
- Employees
- INM N/A
- FTAIM 580
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- FTAIM Misc Corporate Leasing Services
- Sector
- INM Health Care
- FTAIM Industrials
- Exchange
- INM Nasdaq
- FTAIM Nasdaq
- Market Cap
- INM 5.1M
- FTAIM N/A
- IPO Year
- INM N/A
- FTAIM N/A
- Fundamental
- Price
- INM $2.12
- FTAIM $26.93
- Analyst Decision
- INM
- FTAIM
- Analyst Count
- INM 0
- FTAIM 0
- Target Price
- INM N/A
- FTAIM N/A
- AVG Volume (30 Days)
- INM 122.5K
- FTAIM N/A
- Earning Date
- INM 11-13-2025
- FTAIM N/A
- Dividend Yield
- INM N/A
- FTAIM N/A
- EPS Growth
- INM N/A
- FTAIM N/A
- EPS
- INM N/A
- FTAIM N/A
- Revenue
- INM $4,942,633.00
- FTAIM N/A
- Revenue This Year
- INM N/A
- FTAIM N/A
- Revenue Next Year
- INM N/A
- FTAIM N/A
- P/E Ratio
- INM N/A
- FTAIM N/A
- Revenue Growth
- INM 7.50
- FTAIM N/A
- 52 Week Low
- INM $1.72
- FTAIM N/A
- 52 Week High
- INM $8.27
- FTAIM N/A
- Technical
- Relative Strength Index (RSI)
- INM 43.11
- FTAIM 56.05
- Support Level
- INM $2.04
- FTAIM $26.86
- Resistance Level
- INM $2.24
- FTAIM $27.09
- Average True Range (ATR)
- INM 0.14
- FTAIM 0.19
- MACD
- INM -0.01
- FTAIM 0.03
- Stochastic Oscillator
- INM 16.31
- FTAIM 77.70
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.